Neuroblastoma: Current Imaging and Therapeutics

Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 3

Abstract

Neuroblastoma is the most common solid abdominal tumor in children under the age of 2 years and accounts for approximately 15% of childhood mortality due to cancer. Its clinical behavior can vary from spontaneous regression to rapid fatal progression and anywhere in between (e.g. differentiation into benign tumors). Unfortunately, 50% of patients already have metastases at presentation. This marked clinical variability and often advanced presentation at time of diagnosis must be addressed with improved imaging and new treatments, particularly through focus on expanded drug development. Current treatment regimens (surgical resection, chemotherapy, and radiotherapy) have proven to be inadequate for treating advanced disease and frequently cause severe side effects that make them intolerable for many children. Promising new therapies include anti-adhesion therapy and immunotherapy, which uses antibodies to trigger a patient’s own immune system to destroy neuroblastoma cells. Of particular interest in the realm of anti-adhesion is attenuation of NF-κB over-activation. Increased NF-κB activity is thought to play a role in the development of tumor resistance to chemotherapeutic agents and radiation. Therefore, novel drugs to attenuate NF-kB activity could revolutionize treatment by increasing overall treatment effectiveness and allowing for reduced drug and radiation doses for dose-sensitive patients.

Authors and Affiliations

Xudong Huang, Ami K. Patel, Krupa K. Patel, Eva-Maria Ratai

Keywords

Related Articles

Socioeconomic and Age-incidence of Breast Cancer: Modeling Using Artificial Intelligence Technique

Purpose: The majority of women presenting with breast cancer it are not possible to identify specific risk factors. Age is the major factor on breast cancer incidence. Also, poverty status can be classified. Because of t...

Antineoplastic Activity of the Ethyl Acetate Extracts from Co-cultured Marine and Terrestrial Actinomycetes

Treatment of cancer is mainly depending on chemotherapy. A considerable number of antitumor compounds are obtained from microorganisms. Particularly, actinomycetes are the sources of a number of compounds with different...

Association of Activated Partial Thromboplastin Time and Fibrinogen Level in Patients with Polycythemia Vera

Aims: To evaluate the Activated Partial Thromboplastin Time (APTT) and fibrinogen levels in patients with Polycythemia vera (PV). Study Design: Analytical, laboratory, hospital-based, cross sectional study. Place and Dur...

Can Calcium and Magnesium Infusion before and after Oxaliplatin Administration Improves Its Neurotoxic Effect?

Introduction: The oxaliplatin neurotoxicity is one of two distinct phases: an acute and a dose-limiting cumulative phase. Large doses of I.V Ca & Mg is given before and after oxaliplatin in FOLFOX protocol. Aim: We aime...

Could Monocytes Colonized by Circulating Epithelial Cells of the Prostate Gland be a Source of Metastasis of the Adenocarcinoma? A Hypothesis Based on a Previous Study

Background: Recently we reported the successful in vitro cultivation of prostatic epithelial and stromal cells from patients with benign prostatic hyperplasia and adenocarcinoma of the prostate by liquid biopsy. In that...

Download PDF file
  • EP ID EP242956
  • DOI 10.9734/JCTI/2015/16165
  • Views 109
  • Downloads 0

How To Cite

Xudong Huang, Ami K. Patel, Krupa K. Patel, Eva-Maria Ratai (2015). Neuroblastoma: Current Imaging and Therapeutics. Journal of Cancer and Tumor International, 2(3), 89-109. https://europub.co.uk/articles/-A-242956